Guillermo Garcia-Manero, Matteo Giovanni Della Porta, Amer Methqal Zeidan, Rami S. Komrokji, Veronika Pozharskaya, Yinzhi Lai, Daniel E. Lopes de Menezes, Manuel Ugidos Guerrero, Thalia Andrea Farazi, Dimana Miteva, Barkha Aggarwal, Sameer Kalsekar, David Valcárcel, Pierre Fenaux, Jake Shortt, Uwe Platzbecker, Valeria Santini. "Updated overall survival (OS) and long-term transfusion-independence (TI) from the phase 3 COMMANDS trial in erythropoiesis-stimulating agent (ESA)–naive patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6566